Ameritas Advisory Services’s State Street SPDR S&P Biotech ETF XBI Stock Holding History
Bought
Maintained
Sold
Other funds holding XBI
Ameritas Advisory Services's XBI Position: Q1 2026 in Review
Ameritas Advisory Services increased its State Street SPDR S&P Biotech ETF (XBI) stake by 2.7% in Q1 2026, buying an estimated $34.6K and bringing the position to 10,638 shares worth $1.36M. The position accounts for 0.05% of the portfolio, ranked #302.
Ameritas Advisory Services first reported a position in XBI in Q4 2021 and has held it in 18 quarters since. The position peaked at $2.39M in Q4 2022. 813 funds tracked by Wall St. Rank hold XBI as of Q1 2026.
- Ameritas Advisory Services held 10,638 shares of State Street SPDR S&P Biotech ETF worth $1.36M as of Q1 2026.
- Ameritas Advisory Services bought 277 State Street SPDR S&P Biotech ETF shares in Q1 2026, an estimated $34.6K.
- State Street SPDR S&P Biotech ETF made up 0.05% of Ameritas Advisory Services's portfolio in Q1 2026, its #302 holding.
- Ameritas Advisory Services first reported a position in State Street SPDR S&P Biotech ETF in Q4 2021 and has held it in 18 quarters since.
- Ameritas Advisory Services's State Street SPDR S&P Biotech ETF position peaked at $2.39M in Q4 2022.
- 813 funds tracked by Wall St. Rank held State Street SPDR S&P Biotech ETF as of Q1 2026.
Based on Ameritas Advisory Services's 13F filing for Q1 2026, filed 12 May 2026.